Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Articles
Articles
Novel Immunotherapy Approach Encouraging in Advanced Ovarian Cancer
By
Phoebe Starr
Ovarian Cancer
,
Solid Tumors
May 2013, Vol 4, No 4
Washington, DC—A 2-step immunotherapy approach holds promise for women with advanced recurrent ovarian cancer, a disease that has limited therapeutic options.
Read More
CMS’s Proposal to Severely Limit FDG-PET Use for Patients with Cancer Elicits Concern
By
Rosemary Frei, MSc
Health Policy
,
Policies & Guidelines
May 2013, Vol 4, No 4
Read More
Genetically Engineered T Cells for Childhood Leukemia
AACR Annual Meeting
May 2013, Vol 4, No 4
Read More
Positron Emission Tomography Scanning May Identify Stage I NSCLC that Requires Chemotherapy
By
Charles Bankhead
AACR Annual Meeting
May 2013, Vol 4, No 4
Read More
False-Positive Lung Cancer Rates Vary Widely by State
AACR Annual Meeting
May 2013, Vol 4, No 4
Lung cancer false- positive rates varied 20-fold across the United States, raising questions about the potential impact on organized screening programs, according to data presented at the 2013 American Association for Cancer Research annual meeting.
Read More
New Mantle-Cell Regimen Leads to “Remarkable” Response Rate
By
Charles Bankhead
AACR Annual Meeting
May 2013, Vol 4, No 4
A chemotherapy–immunotherapy combination has been shown to be extremely effective in a small clinical trial of previously untreated mantle-cell lymphoma, leading to objective responses in every patient, including complete responses in almost 90%, investigators reported at the 2013 American Association for Cancer Research annual meeting.
Read More
AACR Issues New Policy on Tobacco Use
By
Phoebe Starr
AACR Annual Meeting
May 2013, Vol 4, No 4
Washington, DC—Tobacco use among patients with cancer is an important but often overlooked issue that requires intervention by oncology practices. In recognition of the problem and the gap between the need for intervention and the services delivered, the American Association for Cancer Research (AACR) issued a policy on tobacco use at its 2013 annual meeting.
Read More
Health IT Facilitates Patient Engagement Across Many Settings
By
Caroline Helwick
Practice Management
,
Value Peer-spectives
May 2013, Vol 4, No 4
New Orleans, LA—“Patient engagement” is a healthcare buzz phrase, and a critical part of this concept is patient connectivity to information technology (IT). GetWellNetwork is a patient-focused IT system that aims to empower the patient to improve outcomes in a variety of disease states.
Read More
NCCN Updates Its Clinical Practice Guidelines
By
Audrey Andrews
NCCN Annual Conference
May 2013, Vol 4, No 4
Updates to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines® were presented at the 2013 NCCN annual conference. The updates were minor for most tumor sites, but new guidelines were introduced for penile cancer and for survivorship.
Read More
Cancer Support Program Documents Savings
By
Caroline Helwick
Economics & Value
,
Economics of Cancer Care
May 2013, Vol 4, No 4
A case management program for terminally ill patients with cancer can reduce cancer-related healthcare costs and extend hospice length of stay, according to an analysis of the Cancer Support Program (CSP) of Optum Health, a health services company, which was presented at the 2013 National Comprehensive Cancer Network
®
annual conference.
Read More
Page 262 of 330
259
260
261
262
263
264
265
Top Trending Articles
1.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
2.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
3.
Financial Toxicity in Cancer Care: Why the Conversation Must Start Before Treatment Begins
Jan Hailey, MHL, CMC, CMCO, CMIS, CMOM, CMCA-E/M
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma